- Home
- ACIU vs HPAI Comparison
ACIU vs HPAI Comparison
Compare ACIU & HPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- HPAI
- Stock Information
- Founded
- ACIU 2003
- HPAI 2023
- Country
- ACIU Switzerland
- HPAI Singapore
- Employees
- ACIU N/A
- HPAI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- HPAI
- Sector
- ACIU Health Care
- HPAI
- Exchange
- ACIU Nasdaq
- HPAI NYSE
- Market Cap
- ACIU 247.4M
- HPAI 221.3M
- IPO Year
- ACIU 2016
- HPAI N/A
- Fundamental
- Price
- ACIU $1.77
- HPAI $6.31
- Analyst Decision
- ACIU Strong Buy
- HPAI
- Analyst Count
- ACIU 2
- HPAI 0
- Target Price
- ACIU $12.00
- HPAI N/A
- AVG Volume (30 Days)
- ACIU 185.3K
- HPAI 13.6K
- Earning Date
- ACIU 05-12-2025
- HPAI 03-31-2025
- Dividend Yield
- ACIU N/A
- HPAI N/A
- EPS Growth
- ACIU N/A
- HPAI N/A
- EPS
- ACIU N/A
- HPAI 0.06
- Revenue
- ACIU $30,136,397.00
- HPAI $31,475,664.00
- Revenue This Year
- ACIU N/A
- HPAI N/A
- Revenue Next Year
- ACIU $680.74
- HPAI N/A
- P/E Ratio
- ACIU N/A
- HPAI $112.38
- Revenue Growth
- ACIU 84.51
- HPAI 47.72
- 52 Week Low
- ACIU $1.77
- HPAI $3.07
- 52 Week High
- ACIU $4.98
- HPAI $14.74
- Technical
- Relative Strength Index (RSI)
- ACIU 25.49
- HPAI N/A
- Support Level
- ACIU $1.77
- HPAI N/A
- Resistance Level
- ACIU $2.05
- HPAI N/A
- Average True Range (ATR)
- ACIU 0.12
- HPAI 0.00
- MACD
- ACIU -0.02
- HPAI 0.00
- Stochastic Oscillator
- ACIU 0.00
- HPAI 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About HPAI HELPORT AI LTD
Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.